Keywords: رمی کامل; Rectal cancer; Complete remission; Long course CCRT; Watch and wait;
مقالات ISI رمی کامل (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رمی کامل; Complete remission; Nonrelapse mortality; Postrelapse overall survival; Posttransplantation relapse; Prognostic factors;
Keywords: رمی کامل; 7â+â3; cytarabine 7 days and daunorubicin (3 days); AE; adverse event; alloHSCT; allogeneic hematopoietic stem cell transplant; AML; acute myeloid leukemia; AML-MRC; AML with myelodysplasia-related changes; AR; allelic ratio; BSC; best supportive care
Keywords: رمی کامل; AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: رمی کامل; AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec
Keywords: رمی کامل; AML; acute myeloid leukemia; BSC; best supportive care; CI; confidence interval; CIR; cumulative incidence of relapse; CR; complete remission; CRc; composite CR (includes CR, CRi, and CRp); CRi; CR with incomplete hematologic recovery; CRMRDâ; CR with a
Keywords: رمی کامل; Acute myeloid leukemia; Complete remission; Autologous stem cell transplantation; Haploidentical donor stem cell transplantation;
Keywords: رمی کامل; Complete remission; Hodgkin lymphoma; Period analysis; Survival pattern; Three decades;
Keywords: رمی کامل; AML; Day 14; Bone marrow biopsy; Complete remission; Prognostic factors;
Keywords: رمی کامل; Acute myeloid leukemia; AML; Autologous transplant; Complete remission; CR; Hematopoietic cell transplantation; HCT; Minimal residual disease; MRD;
Keywords: رمی کامل; ADCC; antibody dependent cellular cytotoxicity; AML; acute myeloid leukemia; CMV; cytomegalovirus; CR; complete remission; HL; Hodgkin lymphoma; HLA; human leukocyte antigen; HLH; hemophagocytic lymphohistiocytosis; KIR; killer cell inhibitory immunoglobu
Keywords: رمی کامل; Corticosteroids; cyclophosphamide; minimal change disease (MCD); nephrotic syndrome (NS); immunosuppression; adult-onset MCNS; adults; adolescents; partial remission; complete remission; treatment resistance; relapse; renal survival; acute kidney injury (
Keywords: رمی کامل; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplant; BETi; bromodomain and extra terminal domain inhibitor; CR; complete remission; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; FAB; French-American-
Keywords: رمی کامل; CR; Complete remission; DLBCL; Diffuse large B-cell lymphoma; DNA; Deoxyribonucleic acid; EMZL; Extranodal marginal zone lymphoma; IF; Immunofluorescence; IFRT; Involved field radiotherapy; IHC; Immunohistochemistry; MALT; Mucosa associated lymphoid tissu
Keywords: رمی کامل; AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r
Keywords: رمی کامل; Acute myeloid leukemia; Toll like receptors; Complete remission; Induction therapy
Keywords: رمی کامل; AML; Transplantation; Hematologic recovery; Pretransplantation remission status; Morphologic leukemia-free state; Complete remission;
Keywords: رمی کامل; AML; adult myeloid leukemia; CI; confidence interval; CR; complete remission; hAML; AML arising from a prior hematologic malignancy; HCTCI; hematopoietic cell transplantation-specific comorbidity index; MDS; myelodysplastic syndrome; OR; odds ratio; OS; o
Keywords: رمی کامل; Complete remission; Hepatocellular carcinoma; Thalidomide
Keywords: رمی کامل; autoimmune bullous diseases; childhood pemphigus vulgaris; juvenile pemphigus vulgaris; rituximab; CR; complete remission; Dsg; desmoglein; ELISA; enzyme-linked immunosorbent assay; PF; pemphigus foliaceus; PR; partial remission; PV; pemphigus vulgaris;
Keywords: رمی کامل; Acute myeloid leukemia; Allogeneic stem cell transplantation; Autologous stem cell transplantation; Complete remission; Genetic alterations;
Keywords: رمی کامل; Multiple myeloma; Relapsed/refractory; Complete remission; Prognostic factors; Immunomodulatory drugs; Proteasome inhibitors; Emerging agents;
Keywords: رمی کامل; Treatment; Inflammation; Dysphagia; Steroids; AE; adverse event; BMI; body mass index; CCHMC; Cincinnati Children's Hospital Medical Center; CFR; Code of Federal Regulations; CR; complete remission; EDP; Eosinophilic Esophagitis Diagnostic Panel; EoE; eos
Keywords: رمی کامل; Etoposide; Cyclophosphamide; Acute myeloid leukemia; Complete remission;
Study of DNA methyl transferase 3A mutation in acute myeloid leukemic patients
Keywords: رمی کامل; ASB-PCR; allele- specific blocker PCR; DNMT3A; DNA methyltransferase; BM; bone marrow; WBC; white blood cells; HGB; hemoglobin; CR; complete remission; ID; Induction death; OS; Overall survival; DFS; disease free survival; MPN; myeloproliferative neoplasm
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
Keywords: رمی کامل; WR; Waldeyer's ring; NHL; non-Hodgkin's lymphoma; DLBCL; diffuse large B-cell lymphoma; RT; radiotherapy; IFRT; Involved field radiation therapy; CT; immunochemotherapy; PET-CT; positron emission tomography-computed tomography; DFS; disease free survi
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
Keywords: رمی کامل; Acute myelocytic leukemia (AML); Secondary clone; Myelodysplastic syndrome (MDS); Therapy-related acute myelocytic leukemia (t-AML); Therapy-related myelodysplastic syndrome (t-MDS); AML; acute myelocytic leukemia; APL; acute promyelocytic leukemia; ATO;
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: رمی کامل; ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-
High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia
Keywords: رمی کامل; AML; acute myeloid leukemia; BM; bone marrow; CR; complete remission; FAB; French-American-British; HRMA; high-resolution melting analysis; RQ-PCR; real-time quantitative PCR; ROC; receiver operating characteristic; AUC; area under the ROC curve; OS; over
Sex-specific survival difference in association with HLA-DRB1â04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies
Keywords: رمی کامل; Allogeneic HSCT; HLA allele groups; Lymphoid malignancy; Survival; HLA-DRB1â04; Allo-HSCT; allogeneic haematopoietic stem cell transplantation; ALL; acute lymphoid leukaemia; CI; confidence interval; CLL; chronic lymphoid leukaemia; CMV; cytomegalovirus
Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience
Keywords: رمی کامل; Complete remission; Cytogenetics; Induction; Molecular; Overall survival;
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Keywords: رمی کامل; BReC plot; biomarker response characteristic plot; CEA; carcinoembryonic antigen; Cyfra 21.1; cytokeratin 19 fragment; RECIST; response evaluation criteria in solid tumors; CR; complete remission; PR; partial remission; SD; stable disease; PD; progressive
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: رمی کامل; ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
Keywords: رمی کامل; AP; alternative pathway; C3G; C3 glomerulopathy; C3GN; C3 glomerulonephritis; C3Nef; C3 nephritic factor; C5Nef; C5 nephritic factor; CFB; complement factor B; CFH; complement factor H; CR; complete remission; DDD; dense deposit disease; eGFR; estimated g
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
Keywords: رمی کامل; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; ATG; anti-thymocyte globulin; BM; bone marrow; CBA; coalescent-based analysis; CI; confidence interval; CML/CLL; chronic leukemia, CMV, cytomegalovirus; CP; chronic phase; CR; complete remiss
Overexpression of CTNNB1: Clinical implication in Chinese de novo acute myeloid leukemia
Keywords: رمی کامل; AML; acute myeloid leukemia; BM; bone marrow; CR; complete remission; CN-AML; cytogenetically normal AML; LFS; leukemia free survival; OS; overall survival; RQ-PCR; real-time quantitative PCR; WHO; World Health Organization; CTNNB1; Expression; Prognosis;
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: رمی کامل; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13Â years after denileukin diftitox
Keywords: رمی کامل; CD25; complete remission; denileukin diftitox; E7777; primary cutaneous anaplastic large-cell lymphoma; CLS; capillary leak syndrome; CR; complete remission; CTCL; cutaneous T-cell lymphoma; DD; denileukin diftitox; pcALCL; primary cutaneous anaplastic la
Allogeneic: AdultSequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party o
Keywords: رمی کامل; Acute myeloid leukemia; Complete remission; Allogeneic hematopoietic stem cell transplantation; Sequential conditioning regimen; Intermediate intensity conditioning regimen;
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study
Keywords: رمی کامل; Acute myeloid leukemia; Elderly; Unfit; Low-dose therapy; Gene expression profile; Biomarker; Complete remission;
Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia
Keywords: رمی کامل; AA; aplastic anaemia; AAA; acquired aplastic anaemia; Non-SAA; non-severe AA; VSAA; very severe AA; SAA; severe AA; BM; bone marrow; PB; peripheral blood; PBMCs; peripheral blood mononuclear cells; IST; immunosuppressive therapy; CR; complete remission; I
Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies
Keywords: رمی کامل; AML; acute myelogenous leukemia; ANC; absolute neutrophil counts; CCI; Charlson comorbidity index; CI; confidence interval; CIFN; chemotherapy-induced febrile neutropenia; CR; complete remission; G-CSF; granulocyte colony-stimulating factor; NCCN; Nationa
Reduced ADAMTS-13 level negatively correlates with inflammation factors in plasma of acute myeloid leukemia patients
Keywords: رمی کامل; AML; acute myeloid leukemia; APTT; activated partial thromboplastin time; CR; complete remission; CRP; C-reactive protein; DIC; disseminated intravascular coagulation; ELISA; enzyme-linked immunosorbent assay; FAB; French-American-British classification;
Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial
Keywords: رمی کامل; Mycophenolate mofetil (MMF); prednisone; IgA nephropathy (IgAN); crescents; complete remission; proteinuria; immunosuppression; proliferative lesions; endocapillary hypercellularity; necrosis; biopsy-proven IgAN; renal histology; adverse event; kidney dis
Role of MRP-1 and GST-Pi in MDR and their inhibition by indomethacin in AML
Keywords: رمی کامل; MDR; multidrug resistance; MRP-1; multidrug resistance-associated protein-1; GST-Pi; Glutathione-S-Transferase-Pi; NSAIDs; non-steroidal anti-inflammatory drugs; AML; acute myeloid leukemia; CR; complete remission; UR; un-remitted; DFS; disease-free survi
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: رمی کامل; DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Keywords: رمی کامل; AE; adverse event; BEAMing; beads, emulsification, amplification, and magnetics; BIM; bcl2 interacting mediator of cell death or bcl2-like protein 11; CI; confidence interval; CNS; central nervous system; CR; complete remission; CSF; cerebrospinal fluid;
Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity
Keywords: رمی کامل; AML; acute myeloid leukaemia; CGH; comparative genomic hybridization arrays; CTL; cytotoxic T lymphocyte; qPCR; real time quantitative PCR; CR; complete remission; GvL; graft-versus-leukaemia; HSCT; haematopoietic stem cell transplantation; LICs; leukaemi
The “Mystique” of Acute Leukemia: MPAL-BAL-AUL-ALAL-aBLL-HAL-MLL: Initial presentation of MPAL as extramedullary neurological compromise; A case report and review of literature
Keywords: رمی کامل; MPAL; (Multi Phenotypic Acute Leukemia); BAL; (Biphenotypic Acute Leukemia); AUL; (Acute Undifferentiated Leukemia); ALAL; (Acute Leukemia of Ambiguous Lineage); HAL; (Hybrid Acute Leukemia); MLL; (Mixed Lineage Leukemia); aBLL; (acute BiLineal Leukemia);
Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia
Keywords: رمی کامل; Myeloablative conditioning; Reduced-intensity conditioning; Relapse; Survival; Allogeneic hematopoietic cell transplantation; Flow cytometry; Complete remission; AML